YD Bio Limited (NASDAQ:YDES – Get Free Report)’s stock price shot up 9.8% during mid-day trading on Friday . The stock traded as high as $2.44 and last traded at $2.24. 83,139 shares were traded during mid-day trading, a decline of 74% from the average session volume of 322,873 shares. The stock had previously closed at $2.04.
YD Bio Stock Performance
The business’s 50 day moving average price is $2.89 and its 200-day moving average price is $6.43.
Institutional Investors Weigh In On YD Bio
A hedge fund recently raised its stake in YD Bio stock. Geode Capital Management LLC raised its position in YD Bio Limited (NASDAQ:YDES – Free Report) by 10.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the period. Geode Capital Management LLC owned approximately 0.08% of YD Bio worth $711,000 at the end of the most recent quarter.
YD Bio Company Profile
YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
See Also
- Five stocks we like better than YD Bio
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for YD Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YD Bio and related companies with MarketBeat.com's FREE daily email newsletter.
